| 4711 |
Centers for Disease Control and Prevention |
Html |
en |
Flu and People with Asthma |
Flu and People with Asthma - CDC |
| flu illness milder | 0.605655 |
| acute respiratory diseases | 0.544463 |
| Stay home | 0.474015 |
| Flu vaccines | 0.559236 |
| Pneumococcal vaccines | 0.476966 |
| flu vaccine | 0.558721 |
| lung disease | 0.49353 |
| lung airways | 0.51059 |
| trade name Relenza® | 0.473363 |
| important step | 0.479757 |
| allergy particles | 0.485387 |
| airway infections | 0.502451 |
| sensitive airways | 0.496187 |
| antiviral drug | 0.607376 |
| common medical conditions | 0.543537 |
| different antiviral drug | 0.570828 |
| chest tightness | 0.489686 |
| health departments | 0.47533 |
| common long-term diseases | 0.559157 |
| health conditions | 0.478928 |
| chronic inflammation | 0.499951 |
| asthma attacks | 0.923626 |
| early morning coughing | 0.564648 |
| influenza vaccine | 0.508235 |
|
| trade name Tamiflu® | 0.474002 |
| public schools | 0.477745 |
| flu hospitalizations | 0.565747 |
| Asthma Action Plan | 0.715854 |
| antiviral drugs | 0.556238 |
| antiviral drug treatment | 0.566425 |
| asthma | 0.930157 |
| flu viruses | 0.546587 |
| college health centers | 0.543546 |
| Influenza infection | 0.512599 |
| people | 0.531194 |
| medical care | 0.475999 |
| chemical irritants | 0.493795 |
| lung problems | 0.475053 |
| common medical condition | 0.545232 |
| influenza infections | 0.512655 |
| asthma medications | 0.688112 |
| FluView Interactive application | 0.545185 |
| regular doctor | 0.477146 |
| asthma symptoms | 0.68507 |
| air pollution | 0.485197 |
| trade name Rapivab® | 0.473915 |
| asthma experience symptoms | 0.763311 |
|
CLICK HERE |
| 7124 |
Centers for Disease Control and Prevention |
Html |
en |
Global Health - Kazakhstan |
In 1995, CDC also formally established an office (CDC-Central Asia Region—CDC-CAR) in Almaty, Kazakhstan to serve as the home base for coordinating activities throughout the Central Asia Region. |
| especially dangerous pathogens | 0.555494 |
| Global Disease Detection | 0.574091 |
| HIV prevention | 0.604977 |
| Laboratory Training Program | 0.598495 |
| core infrastructure requirements | 0.558528 |
| health information | 0.521075 |
| Kazakhstan | 0.757908 |
| CAR GDD Center | 0.611286 |
| emergency operations center | 0.57221 |
| Initial exploratory work | 0.561151 |
| country’s health | 0.524318 |
| treatment services | 0.581452 |
| CDC CAR | 0.909634 |
| HIV epidemics | 0.557248 |
| international influenza virus | 0.708331 |
| World Health Organization | 0.599097 |
| national strategic laboratory | 0.603343 |
| public health officers | 0.596575 |
| field epidemiology | 0.576736 |
| Kazakhstan’s laboratories | 0.629415 |
| Crimean-Congo hemorrhagic fever | 0.565868 |
| Kyrgyz Republic | 0.586741 |
| large scale project | 0.579813 |
| FELTP CAR | 0.587605 |
|
| government’s health | 0.531964 |
| surveillance program evaluations | 0.617278 |
| future in-country specialists | 0.567894 |
| International Health Regulations | 0.602593 |
| AIDS Centers | 0.588125 |
| Biological Engagement Program | 0.574831 |
| influenza virus monitoring | 0.593329 |
| Global Health Security | 0.598209 |
| sentinel surveillance sites | 0.588038 |
| GDD Regional Centers | 0.59293 |
| influenza virus banks | 0.58682 |
| direct technical assistance | 0.573279 |
| public health threats | 0.763293 |
| Infant mortality rate | 0.569535 |
| methadone assisted treatment | 0.576116 |
| GDD Regional Center | 0.594229 |
| reliable real-time data | 0.573651 |
| National Influenza Center | 0.597509 |
| electronic HIV case | 0.636521 |
| health systems capacity | 0.621702 |
| Central Asia Regional | 0.609798 |
| HIV care | 0.552677 |
| HIV counseling | 0.548297 |
| pandemic influenza response | 0.587731 |
|
CLICK HERE |
| 7237 |
Centers for Disease Control and Prevention |
Html |
en |
Race/Ethnicity, Adults 18 to 64 Years at High-Risk - Estimates from the Behavioral Risk Factor Surveillance System (BRFSS), National Immunization Survey (NIS), and the National 2009 H1N1 Flu Survey (NHFS) |
Recent Influenza Vaccination Trends across Influenza Seasons, Race/Ethnicity, Adults 18 to 64 Years at High-Risk - CDC |
| Native Hawaiian | 0.464381 |
| Pacific Islander | 0.502838 |
| data | 0.4013 |
| report Final estimates | 0.514647 |
| season estimates | 0.296643 |
| United States | 0.294922 |
| influenza vaccination coverage | 0.634671 |
| methods | 0.292747 |
| U.S. civilian population | 0.439034 |
| Risk Factor Surveillance | 0.461868 |
| recent influenza seasons | 0.404222 |
| seasonal influenza vaccination | 0.944707 |
| Monovalent Vaccination Coverage | 0.504542 |
| vaccination coverage | 0.690707 |
| Alaska Native | 0.464849 |
| Excludes U.S. territories | 0.467599 |
| heart disease | 0.428748 |
| Additional estimates | 0.301372 |
| lung conditions | 0.290325 |
| estimates | 0.772504 |
|
| high risk conditions | 0.65774 |
| National Immunization Survey | 0.275288 |
| vaccination periods | 0.314879 |
| data sources | 0.218495 |
| influenza season | 0.46984 |
| high-risk conditions | 0.205707 |
| kidney conditions | 0.290541 |
| H1N1 Flu Survey | 0.443999 |
| Table 6-B | 0.204936 |
| Table 6-A | 0.204699 |
| confidence interval half-width | 0.462975 |
| BRFSS adult estimates | 0.386344 |
| Coverage estimates | 0.319447 |
| chronic illness | 0.464534 |
| Data Source | 0.384611 |
| vaccination recommendations | 0.31928 |
| vaccination data | 0.350914 |
| analytic methods | 0.206856 |
| national weighted estimates | 0.413234 |
| Behavioral Risk Factor | 0.462177 |
|
CLICK HERE |
| 7389 |
Centers for Disease Control and Prevention |
Html |
en |
ADHD Prevalence - NCBDDD |
null |
| Holbrook J. R. | 0.483953 |
| previous national survey | 0.495149 |
| CDC | 0.466904 |
| Mortality Weekly Report | 0.483229 |
| Birth Defects | 0.456615 |
| current ADHD diagnosis | 0.700758 |
| Health Sciences Center | 0.515084 |
| behavioral health conditions | 0.490341 |
| community-based studies | 0.496939 |
| children | 0.627872 |
| Attention-Deficit/Hyperactivity Disorder | 0.574704 |
| school districts | 0.495766 |
| National Center | 0.467211 |
| intervention strategies | 0.455991 |
| NCHS data brief | 0.490663 |
| good treatment plans | 0.497128 |
| previous community-based estimates | 0.500348 |
| parent-reported survey data | 0.493025 |
| clinical practice guidelines | 0.490964 |
| ADHD case definition | 0.816018 |
| DSM-IV ADHD criteria | 0.704667 |
| ADHD symptoms | 0.668194 |
| Clinical Practice Guideline | 0.486453 |
| single treatment | 0.456117 |
| deficit hyperactivity disorder | 0.492 |
|
| ADHD | 0.942905 |
| Developmental Disabilities | 0.455696 |
| multisite Project | 0.459169 |
| Parent-Reported Attention-Deficit/Hyperactivity Disorder | 0.505362 |
| United States | 0.537283 |
| epidemiologic studies | 0.459505 |
| clinical practice | 0.49479 |
| common neurobehavioral disorder | 0.500338 |
| South Carolina | 0.511658 |
| DSM-IV-based case definition | 0.514259 |
| elementary school-aged children | 0.528641 |
| ADHD medication | 0.806962 |
| Public Health Practice | 0.491029 |
| study methods | 0.455947 |
| comparison children | 0.47632 |
| Attention Disorders1 | 0.45613 |
| National Resource Center | 0.552483 |
| potential public health | 0.509858 |
| disruptive behavioral disorders | 0.486306 |
| ADHD prevalence rates | 0.732866 |
| health care practitioners | 0.493479 |
| study criteria | 0.457128 |
| behavioral disorders | 0.48977 |
| PLAY study | 0.499887 |
|
CLICK HERE |
| 8735 |
Centers for Disease Control and Prevention |
Html |
en |
Announcements: Recommendations Regarding CardiovascularDisease from the Community Preventive Services Task Force |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.488933 |
| prevention experts | 0.471074 |
| CDC | 0.503778 |
| endorsement | 0.388654 |
| Human Services | 0.765703 |
| assistive technology | 0.49531 |
| U.S. Department | 0.774957 |
| MMWR HTML versions | 0.59663 |
| task force | 0.948484 |
| electronic PDF version | 0.582076 |
| new information | 0.485907 |
| e-mail | 0.357974 |
| High Cholesterol | 0.478817 |
| population health | 0.47702 |
| Contact GPO | 0.496383 |
| http://www.thecommunityguide.org/cvd/ropc.html | 0.329309 |
| commercial sources | 0.4647 |
| decision makers | 0.463075 |
| current prices | 0.45654 |
| original paper copy | 0.577794 |
| Cardiovascular Disease Prevention | 0.633984 |
| programs | 0.352183 |
| wide range | 0.469317 |
| original MMWR paper | 0.589761 |
|
| U.S. Government Printing | 0.585508 |
| Disease Preventive Services | 0.6565 |
| Superintendent | 0.330538 |
| unpaid panel | 0.474549 |
| assistance | 0.330369 |
| title | 0.328565 |
| MMWR readers | 0.470914 |
| character translation | 0.455045 |
| technical support | 0.467119 |
| file | 0.330563 |
| Persons | 0.330679 |
| public health | 0.486202 |
| format errors | 0.459518 |
| subject line | 0.47801 |
| typeset documents | 0.466347 |
| trade names | 0.464841 |
| Services Task Force | 0.723889 |
| official text | 0.452759 |
| Out-of-Pocket Costs | 0.487731 |
| non-CDC sites | 0.462556 |
| report | 0.328541 |
| Accommodation | 0.328588 |
| electronic conversions | 0.453701 |
| High Blood Pressure | 0.622255 |
|
CLICK HERE |
| 11521 |
Centers for Disease Control and Prevention |
Html |
en |
NCIRD | Influenza Division | Branch Chief Bios | Nancy Cox | CDC |
null |
| avian influenza | 0.348752 |
| book chapters | 0.300073 |
| Charles C. Shepard | 0.266832 |
| deputy director | 0.316441 |
| Global Influenza Surveillance | 0.39968 |
| global influenza virus | 0.398752 |
| pandemic influenza viruses | 0.472697 |
| seasonal influenza viruses | 0.451488 |
| Influenza Division. | 0.354676 |
| Dr. Wentworth | 0.282014 |
| novel influenza viruses | 0.535789 |
| H1N1 pandemic influenza | 0.473399 |
| CDC Influenza Division | 0.481037 |
| animal influenza viruses | 0.421351 |
| influenza vaccine | 0.481269 |
| Epidemic Intelligence Service | 0.469056 |
| Diarrheal Diseases Branch | 0.30065 |
| Dr. Tumpey | 0.305681 |
| CDC’s Division | 0.264666 |
| Influenza Division | 0.9475 |
| influenza surveillance | 0.410072 |
| University | 0.265115 |
| Influenza Vaccine Introduction | 0.421633 |
| influenza disease burden | 0.419884 |
| Influenza Branch | 0.497477 |
|
| Dr. | 0.458601 |
| novel influenza | 0.539062 |
| Respiratory Diseases Branch | 0.331258 |
| pandemic influenza | 0.587122 |
| global influenza pandemic | 0.435077 |
| Dr. Bresee | 0.306489 |
| CDC’s Influenza | 0.537165 |
| peer-reviewed research articles | 0.278758 |
| novel influenza vaccine | 0.412515 |
| public health | 0.60154 |
| influenza virology | 0.389736 |
| U.S. Public Health | 0.295017 |
| influenza vaccines | 0.363766 |
| Dr. Fry | 0.273441 |
| Dr. Katz | 0.380031 |
| Influenza Program Director | 0.410673 |
| influenza virus efforts | 0.38109 |
| influenza infections | 0.365069 |
| H1N1 influenza pandemic | 0.472638 |
| influenza viruses | 0.736554 |
| Public Health Service | 0.368191 |
| Pathogenesis Branch | 0.273813 |
| Dr. Jernigan | 0.45023 |
| CDC’s Epidemic | 0.269066 |
|
CLICK HERE |
| 11967 |
Centers for Disease Control and Prevention |
Html |
en |
NIOSH-Approved N99 Particulate Filtering Facepiece Respirators - Suppliers List |
This page contains a suppliers list of NIOSH-Approved N99 Particulate Filtering Facepiece Respirators. |
| PDF version | 0.711788 |
| facepiece respirator | 0.852905 |
| airborne particles | 0.845824 |
| CDC/NIOSH | 0.553908 |
| procedure | 0.482707 |
| Disclaimer | 0.5265 |
| official endorsement | 0.84325 |
|
| content | 0.496522 |
| N99 | 0.56554 |
| NIOSH policy | 0.955076 |
| oil | 0.463497 |
| statement | 0.495902 |
| websites | 0.498321 |
| links | 0.457956 |
|
CLICK HERE |
| 13559 |
Centers for Disease Control and Prevention |
Html |
null |
Effect of Family Income on the Relationship Between Parental Education and Sealant Prevalence, National Health and Nutrition Examination Survey, 2005–2010 |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
|
|
CLICK HERE |
| 13623 |
Centers for Disease Control and Prevention |
Html |
en |
Change of School in Early Adolescence and Adverse Obesity-Related Dietary Behavior: A Longitudinal Cohort Study, Victoria, Australia, 2013–2014 |
Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. PCD provides an open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. |
| Secondary school food | 0.620622 |
| secondary school students | 0.618271 |
| school | 0.935854 |
| vegetable classroom breaks | 0.598808 |
| secondary school | 0.793718 |
| Deakin University | 0.585918 |
| School staff surveys | 0.603612 |
| school staff | 0.624411 |
| non-core food items | 0.691747 |
| primary schools | 0.624336 |
| obesity-related dietary behavior | 0.630941 |
| school food service | 0.601341 |
| early adolescence | 0.590614 |
| School canteen manager | 0.603386 |
| healthy eating | 0.787151 |
| school environment surveys | 0.591069 |
| dietary behavior | 0.707557 |
| School teacher surveys | 0.5891 |
| discrete primary school | 0.603006 |
| schools | 0.784177 |
| food services | 0.584218 |
| school encourage students | 0.611702 |
| school food environments | 0.674536 |
| P–12 school | 0.589281 |
|
| school environment | 0.773749 |
| School staff members | 0.592233 |
| healthy canteen policies | 0.584544 |
| students | 0.761851 |
| school type | 0.654412 |
| primary school | 0.698872 |
| mixed model regression | 0.617883 |
| secondary school canteens | 0.59963 |
| healthy eating food | 0.590731 |
| physical school environment | 0.591061 |
| discrete secondary school | 0.607313 |
| weight status | 0.680258 |
| school state authority | 0.588925 |
| school food environment | 0.814217 |
| sugar-sweetened beverages | 0.708724 |
| intake | 0.611976 |
| school social environment | 0.591073 |
| school environments | 0.590102 |
| secondary schools | 0.720145 |
| School perception responses | 0.584642 |
| vegetable intake | 0.600157 |
| School principal surveys | 0.586947 |
| school staff survey | 0.602811 |
| school types | 0.591566 |
|
CLICK HERE |
| 13760 |
Centers for Disease Control and Prevention |
Html |
en |
Lassa Fever | CDC |
null |
| acute viral illness | 0.555631 |
| Côte d’Ivoire | 0.378855 |
| Benin | 0.239534 |
| traveler | 0.232071 |
| Guinea | 0.230988 |
| Sierra Leone | 0.553424 |
| areas | 0.227327 |
| Lassa virus | 0.961687 |
| neighboring countries | 0.373882 |
| number | 0.227066 |
| infections | 0.230142 |
| member | 0.229849 |
| Lassa virus infection | 0.796045 |
| Mastomys natalensis | 0.384598 |
| Nigeria | 0.348979 |
| deaths | 0.231881 |
| case | 0.228269 |
| estimates | 0.231357 |
| cases | 0.322849 |
|
| disease | 0.253995 |
| Togo | 0.240133 |
| town | 0.230653 |
| impact | 0.226943 |
| Ghana | 0.233918 |
| southern Mali | 0.38339 |
| people | 0.227123 |
| Liberia | 0.298474 |
| Lassa fever | 0.981187 |
| single-stranded RNA virus | 0.640213 |
| Burkina Faso | 0.383333 |
| parts | 0.229234 |
| risk | 0.228952 |
| missionary nurses | 0.377898 |
| animal vector | 0.366106 |
| region | 0.255964 |
| virus family Arenaviridae | 0.610995 |
| serologic evidence | 0.35554 |
| west Africa | 0.687383 |
|
CLICK HERE |